Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Perry

Showing results (71-80 of 108) with videos related to

Pageof 11
Sort By:
Journal of Neuro-Oncology|November 16, 2020
Quantitative CEST and MT at 1.5T for monitoring treatment response in glioblastoma: early and late tumor progression during chemoradiationRachel W Chan, Hanbo Chen, Sten Myrehaug, et al.
Oncotarget|February 27, 2016
Cilengitide in newly diagnosed glioblastoma: biomarker expression and outcomeMichael Weller, Louis Burt Nabors, Thierry Gorlia, et al.
Neuro-Oncology|May 6, 2020
Neuro-oncology Management During the COVID-19 Pandemic With a Focus on WHO Grade III and IV GliomasDenise Bernhardt, Wolfgang Wick, Stephanie E Weiss, et al.
Journal of Virology|June 27, 2014
Characterization and immunogenicity of a novel mosaic M HIV-1 gp140 trimerJoseph P Nkolola, Christine A Bricault, Ann Cheung, et al.
International Journal of Radiation Oncology, Biology, Physics|March 28, 2025
Temporal Apparent Diffusion Coefficient Changes During Chemoradiation: An Imaging Biomarker for Tumor Response Monitoring and Spatial Recurrence Prediction in GlioblastomaDaniel Moore-Palhares, Liam S P Lawrence, Sten Myrehaug, et al.
AJNR. American Journal of Neuroradiology|August 6, 2024
Gadolinium-Enhanced T2 FLAIR Is an Imaging Biomarker of Radiation Necrosis and Tumor Progression in Patients with Brain MetastasesChris Heyn, Jonathan Bishop, Alan R Moody, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2013
MicroRNA-31 predicts the presence of lymph node metastases and survival in patients with lung adenocarcinomaWei Meng, Zhenqing Ye, Ri Cui, et al.
International Journal of Radiation Oncology, Biology, Physics|April 1, 2024
Predictors of Tumor Dynamics Over a 6-Week Course of Concurrent Chemoradiotherapy for Glioblastoma and the Effect on SurvivalWee Loon Ong, James Stewart, Arjun Sahgal, et al.
Communications Biology|April 8, 2022
An Amish founder population reveals rare-population genetic determinants of the human lipidomeMay E Montasser, Stella Aslibekyan, Vinodh Srinivasasainagendra, et al.
International Journal of Radiation Oncology, Biology, Physics|October 17, 2020
Quantitating Interfraction Target Dynamics During Concurrent Chemoradiation for Glioblastoma: A Prospective Serial Imaging StudyJames Stewart, Arjun Sahgal, Young Lee, et al.
Pageof 11

Showing results (71-80 of 108) with videos related to

Sort By:
Pageof 11
Journal of Neuro-Oncology|November 16, 2020
Quantitative CEST and MT at 1.5T for monitoring treatment response in glioblastoma: early and late tumor progression during chemoradiationRachel W Chan, Hanbo Chen, Sten Myrehaug, et al.
Oncotarget|February 27, 2016
Cilengitide in newly diagnosed glioblastoma: biomarker expression and outcomeMichael Weller, Louis Burt Nabors, Thierry Gorlia, et al.
Neuro-Oncology|May 6, 2020
Neuro-oncology Management During the COVID-19 Pandemic With a Focus on WHO Grade III and IV GliomasDenise Bernhardt, Wolfgang Wick, Stephanie E Weiss, et al.
Journal of Virology|June 27, 2014
Characterization and immunogenicity of a novel mosaic M HIV-1 gp140 trimerJoseph P Nkolola, Christine A Bricault, Ann Cheung, et al.
International Journal of Radiation Oncology, Biology, Physics|March 28, 2025
Temporal Apparent Diffusion Coefficient Changes During Chemoradiation: An Imaging Biomarker for Tumor Response Monitoring and Spatial Recurrence Prediction in GlioblastomaDaniel Moore-Palhares, Liam S P Lawrence, Sten Myrehaug, et al.
AJNR. American Journal of Neuroradiology|August 6, 2024
Gadolinium-Enhanced T2 FLAIR Is an Imaging Biomarker of Radiation Necrosis and Tumor Progression in Patients with Brain MetastasesChris Heyn, Jonathan Bishop, Alan R Moody, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2013
MicroRNA-31 predicts the presence of lymph node metastases and survival in patients with lung adenocarcinomaWei Meng, Zhenqing Ye, Ri Cui, et al.
International Journal of Radiation Oncology, Biology, Physics|April 1, 2024
Predictors of Tumor Dynamics Over a 6-Week Course of Concurrent Chemoradiotherapy for Glioblastoma and the Effect on SurvivalWee Loon Ong, James Stewart, Arjun Sahgal, et al.
Communications Biology|April 8, 2022
An Amish founder population reveals rare-population genetic determinants of the human lipidomeMay E Montasser, Stella Aslibekyan, Vinodh Srinivasasainagendra, et al.
International Journal of Radiation Oncology, Biology, Physics|October 17, 2020
Quantitating Interfraction Target Dynamics During Concurrent Chemoradiation for Glioblastoma: A Prospective Serial Imaging StudyJames Stewart, Arjun Sahgal, Young Lee, et al.
Pageof 11